Skip to main content
. 2020 May 26;15(13):1139–1149. doi: 10.1002/cmdc.202000147

Figure 1.

Figure 1

Structures of the broad‐spectrum 2OG oxygenase inhibitors 2,4‐PDCA (1) and NOG (2) and the PHD selective inhibitor roxadustat (3)11a and the KDM4‐selective inhibitor QC‐6352 (4).14